Eliem Therapeutics, Inc - Common Stock (NQ:ELYM)

5.110 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eliem Therapeutics, Inc - Common Stock

< Previous 1 2 3 4 Next >

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

October 02, 2024

From Eliem Therapeutics, Inc.

Via GlobeNewswire

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit

September 11, 2024

From Eliem Therapeutics, Inc.

Via GlobeNewswire

Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday ↗

August 29, 2024

Via Benzinga

Eliem Therapeutics Announces Additions to its Leadership Team

August 26, 2024

From Eliem Therapeutics, Inc.

Via GlobeNewswire

ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q2 2024 ↗

August 14, 2024

Eliem Therapeutics just reported results for the second quarter of 2024.

Via InvestorPlace

Eliem Therapeutics Reports Second Quarter Financial Results

August 14, 2024

From Eliem Therapeutics, Inc.

Via GlobeNewswire

IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday ↗

July 22, 2024

Via Benzinga

Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes

June 28, 2024

From Eliem Therapeutics, Inc.

Via GlobeNewswire

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement

June 27, 2024

From Eliem Therapeutics, Inc.

Via GlobeNewswire

ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q1 2024 ↗

May 15, 2024

Eliem Therapeutics just reported results for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 03, 2024

Via Benzinga

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 12, 2024

Via Benzinga

Nasdaq Jumps 250 Points; Crude Oil Down 1% ↗

April 11, 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83....

Via Benzinga

Topics Stocks

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 11, 2024

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Via Benzinga

Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal ↗

April 11, 2024

Eliem Therapeutics will acquire Tenet Medicines, focusing on advancing TNT119, an anti-CD19 antibody for autoimmune diseases. Strategic alternatives explored. $120 million private placement....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 11, 2024

Via Benzinga

Dow Dips 100 Points; CarMax Earnings Miss Views ↗

April 11, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday.

Via Benzinga

Topics Earnings Stocks

Nasdaq Gains Over 50 Points; US Producer Prices Increase In March ↗

April 11, 2024

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94....

Via Benzinga

Topics Stocks

ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders

April 11, 2024

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 11, 2024

Via Benzinga

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

April 11, 2024

From Eliem Therapeutics, Inc.

Via GlobeNewswire

ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023 ↗

April 05, 2024

Eliem Therapeutics just reported results for the fourth quarter of 2023.

Via InvestorPlace

Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 21, 2023

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 21, 2023

Via Benzinga

Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket ↗

July 21, 2023

Gainers BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 21, 2023

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

What's Happening With Eliem Therapeutics Shares Today? ↗

July 20, 2023

Eliem Therapeutics Inc (NASDAQ: ELYM) shares are trading higher after the company completed a review of its business, including the status of its programs,

Via Benzinga

Why Is BioSig Technologies (BSGM) Stock Up 19% Today? ↗

July 20, 2023

BioSig Technologies (BSGM) stock is rising higher on Thursday as subsidiary BioSig AI Sciences joins Nvidia's (NVDA) Inception program.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.